Superstring Capital Management Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$140.0M
Q ending 2026-03-31
Prior quarter
$186.8M
Q ending 2025-12-31
Change
-25.1% QoQ · +66.5% YoY
Positions
35
reported holdings
Largest positions
All 35 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Summit Therapeutics Inc | SMMT | Shares | $16.9M | 893K |
| Immunovant Inc | IMVT | Shares | $8.9M | 358K |
| Cogent Biosciences Inc | COGT | Shares | $8.7M | 225K |
| Savara Inc | SVRA | Shares | $8.7M | 1.6M |
| Urogen Pharma Ltd | Shares | $7.0M | 387K | |
| Definium Therapeutics Inc | DFTX | Shares | $6.6M | 351K |
| Vir Biotechnology Inc | VIR | Shares | $6.5M | 731K |
| Vaxcyte Inc | PCVX | Shares | $6.4M | 110K |
| Celldex Therapeutics Inc New | CLDX | Shares | $5.7M | 180K |
| Sionna Therapeutics Inc | SION | Shares | $5.7M | 141K |
| Genmab A/S | GMAB | Shares | $5.3M | 197K |
| Zai Lab Ltd | ZLAB | Shares | $5.2M | 276K |
| Vertex Pharmaceuticals Inc | VRTX | Shares | $4.9M | 11K |
| Iqvia Hldgs Inc | IQV | Shares | $4.4M | 26K |
| Maplight Therapeutics Inc | MPLT | Shares | $3.9M | 192K |
| Arvinas Inc | ARVN | Shares | $3.3M | 313K |
| Oruka Therapeutics Inc | ORKA | Shares | $3.1M | 64K |
| United Therapeutics Corp Del | UTHR | Shares | $3.1M | 5K |
| Travere Therapeutics Inc | TVTX | Shares | $3.1M | 103K |
| Trevi Therapeutics Inc | TRVI | Shares | $3.0M | 252K |
| Adlai Nortye Ltd | ANL | Shares | $2.9M | 415K |
| Cabaletta Bio Inc | CABA | Shares | $2.9M | 1.1M |
| Pfizer Inc | PFE | Shares | $2.1M | 74K |
| Axsome Therapeutics Inc. | AXSM | Shares | $1.9M | 11K |
| Oric Pharmaceuticals Inc | ORIC | Shares | $1.5M | 115K |
| Aclaris Therapeutics Inc | ACRS | Shares | $1.4M | 366K |
| Climb Bio Inc | CLYM | Shares | $1.4M | 199K |
| Taysha Gene Therapies Inc | TSHA | Shares | $1.2M | 258K |
| Bright Minds Biosciences Inc | DRUG | Shares | $971K | 13K |
| Tonix Pharmaceuticals Hldg C | TNXP | Shares | $874K | 64K |
| Cullinan Therapeutics Inc | CGEM | Shares | $845K | 59K |
| Protara Therapeutics Inc | TARA | Shares | $633K | 121K |
| Palatin Technologies Inc | PTN | Shares | $627K | 36K |
| Biomea Fusion Inc | BMEA | Shares | $383K | 250K |
| Century Therapeutics Inc | IPSC | Shares | $270K | 119K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.